💙 Gate Square #Gate Blue Challenge# 💙
Show your limitless creativity with Gate Blue!
📅 Event Period
August 11 – 20, 2025
🎯 How to Participate
1. Post your original creation (image / video / hand-drawn art / digital work, etc.) on Gate Square, incorporating Gate’s brand blue or the Gate logo.
2. Include the hashtag #Gate Blue Challenge# in your post title or content.
3. Add a short blessing or message for Gate in your content (e.g., “Wishing Gate Exchange continued success — may the blue shine forever!”).
4. Submissions must be original and comply with community guidelines. Plagiarism or re
Today, the focus of the Crypto Assets market is concentrated on the performance of Solana (SOL). $190 has become a key price level closely watched by market participants. If SOL can firmly maintain above $190, it will indicate that the long positions trend is still strong and is expected to drive the price further up, with the next important resistance level possibly appearing around $195 and $202.
However, if SOL fails to hold the $190 level, it may trigger a short-term pullback. In this case, investors should closely follow the support levels around $187 and $178.
At the same time, the Crypto Assets market is also influenced by several macro factors. Notably, the U.S. July Producer Price Index (PPI) year-on-year rate exceeded expectations, which may have a certain impact on market sentiment. Additionally, the Federal Reserve has canceled an innovative activity regulatory plan, a decision that could have far-reaching effects on the fintech and Crypto Assets industry.
The market has also observed some interesting trends, such as the phenomenon of mainstream Crypto Assets rotating and rising, as well as the growing interest of Chinese investors in the Indonesian market. These trends reflect global investors' ongoing search for new investment opportunities and markets.
Overall, the Crypto Assets market remains vibrant and uncertain. Investors need to closely follow various market signals and macroeconomic indicators to make informed investment decisions.